Cell Separation

Somatic cell therapies for stem cell transplant, adoptive immunotherapies, and regenerative medicine forecast the next chapter in healthcare as the foundations for new forms of treatment. While the potential seems unlimited, there is still much to learn about cell differentiation, transplantation and engraftment. Translating stem cell research into successful clinical therapies will require years of intensive research. Pall provides researchers with tools to take novel cell therapies from the laboratory to the clinic.

Purecell™ Select System for MNC Enrichment

Cell Separation: Purecell™ Select System for MNC Enrichment

Put your density gradient separations in the fast lane.
Speed up MNC enrichment
and obtain higher recoveries
than ever before!

 





Support/Resources

   

Related Industry Links

Contact Us

Questions or comments? Please email us or contact your local Pall office:

Australia - Cheltenham, VIC
Tel: 03 9584 8100
800 635 082 (in Australia)
Fax: 1800 226 825

Brazil - Rio de Janeiro
Tel: (5521) 2111.92.08
Fax: (5521) 2111.92.05

Canada - Ontario
Tel: 905-542-0330
800-263-5910 (in Canada)
Fax: 905-542-0331

Canada - Québec
Tel: 514.332.7255
800.435.6266 (in Canada)

Germany - Dreieich
Tel: 06103.307.333
Fax: 06103.307.399

India - Mumbai
Tel: +91 22 67995555 or +91 22 66830700
Fax: +91 22 67995556

Korea - Seoul
Tel: 82.2.560.8711
Fax: 82.2.569.9095

Thailand - Bangkok
Tel: (66) 2937 1055
Fax: (66) 2937 1066

United Kingdom - Portsmouth
Tel: +44 (0)23 9230 3452
Fax: +44 (0)23 9230 3324
Biosvc@Pall.com

United States
Phone: 877.367.7255
Fax: 888.556.7337
pall@rxcrossroads.com